Shock therapy to treat the Novel Coronavirus Disease (COVID-19) by ddNTPs
<p>The Novel Coronavirus (SARS-CoV-2) has caused a massive global outbreak, presenting a significant public health emergency and international concern. Thousands of critically ill patients are dying daily. To date, there are no clinically approved antiviral drug available to cure the Novel Cor...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Książka |
| Wydane: |
Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications,
2020-05-20.
|
| Hasła przedmiotowe: | |
| Dostęp online: | Connect to this object online. |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_2455-5363_000029 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yeping Tan |e author |
| 245 | 0 | 0 | |a Shock therapy to treat the Novel Coronavirus Disease (COVID-19) by ddNTPs |
| 260 | |b Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications, |c 2020-05-20. | ||
| 520 | |a <p>The Novel Coronavirus (SARS-CoV-2) has caused a massive global outbreak, presenting a significant public health emergency and international concern. Thousands of critically ill patients are dying daily. To date, there are no clinically approved antiviral drug available to cure the Novel Coronavirus infections. I highly recommend the clinical trial of 2',3'-dideoxyribonucleoside triphosphate (ddNTPs, except ddTTP) to be used for the Novel Coronavirus Disease (COVID-19) antiviral therapy.</p> | ||
| 540 | |a Copyright © Yeping Tan et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Opinion |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/2455-5363.000029 |z Connect to this object online. |